Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol
Resumen:
Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.
| 2024 | |
|
COVID-19 Maternal medicine Perinatology VACUNAS CONTRA LA COVID-19 PERINATOLOGÍA EFECTOS ADVERSOS A LARGO PLAZO EPIDEMIOLOGÍA PREVENCIÓN DE ENFERMEDADES ESTUDIOS DE CASOS Y CONTROLES MUJERES EMBARAZO ENSAYOS CLÍNICOS COMO ASUNTO RETARDO DEL CRECIMIENTO FETAL INMUNIZACIÓN VACUNACIÓN RECIÉN NACIDO RECIÉN NACIDO PREMATURO ESTUDIOS RETROSPECTIVOS MORTINATO VACUNAS |
|
| Inglés | |
| Universidad de la República | |
| COLIBRI | |
| https://hdl.handle.net/20.500.12008/56078 | |
| Acceso abierto | |
| Licencia Creative Commons Atribución (CC - By 4.0) |
| _version_ | 1875692832885309440 |
|---|---|
| author | Macías Saint-Gerons, Diego |
| author2 | Castro, José Luis Colomar, Mercedes Rojas, Edgard Sosa, Claudio Ropero, Alba María Jacob Serruya, Suzanne Pastor, Desiré Chiu, Mónica Velandia-Gonzalez, Martha Abalos, Edgardo Durán, Pablo Gomez Ponce de León, Rodolfo Tomasso, Giselle Mainero, Luis Rubino, Marcelo De Mucio, Bremen |
| author2_role | author author author author author author author author author author author author author author author author |
| author_facet | Macías Saint-Gerons, Diego Castro, José Luis Colomar, Mercedes Rojas, Edgard Sosa, Claudio Ropero, Alba María Jacob Serruya, Suzanne Pastor, Desiré Chiu, Mónica Velandia-Gonzalez, Martha Abalos, Edgardo Durán, Pablo Gomez Ponce de León, Rodolfo Tomasso, Giselle Mainero, Luis Rubino, Marcelo De Mucio, Bremen |
| author_role | author |
| bitstream.checksum.fl_str_mv | 6429389a7df7277b72b7924fdc7d47a9 a0ebbeafb9d2ec7cbb19d7137ebc392c c2be1a593bc16fa3ffa80ce838a200ca e7132498e7c1fe99f7096667baa99b25 c2a37d8e741656a7970bf5ee53588199 |
| bitstream.checksumAlgorithm.fl_str_mv | MD5 MD5 MD5 MD5 MD5 |
| bitstream.url.fl_str_mv | http://localhost:8080/xmlui/bitstream/20.500.12008/56078/5/license.txt http://localhost:8080/xmlui/bitstream/20.500.12008/56078/2/license_url http://localhost:8080/xmlui/bitstream/20.500.12008/56078/3/license_text http://localhost:8080/xmlui/bitstream/20.500.12008/56078/4/license_rdf http://localhost:8080/xmlui/bitstream/20.500.12008/56078/1/Description+of+maternal+and+neonatal+adverse+events+in+pregnant+people+immunised+with+COVID19+vaccines.pdf |
| collection | COLIBRI |
| dc.contributor.filiacion.none.fl_str_mv | Macías Saint-Gerons Diego, Universidad de Valencia (España). Instituto de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Salud Mental. Departamento de Medicina Castro José Luis, Fundación para la Innovación, la Formación, la Investigación y el Desarrollo Comunitario (España) Colomar Mercedes, Universidad de la República (Uruguay). Facultad de Medicina. Departamento de Medicina Preventiva y Social; Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay) Rojas Edgard, Pan American Health Organization (E.E.U.U.). Innovation, Access to Medicines and Health Technologies Sosa Claudio, Universidad de la República (Uruguay). Facultad de Medicina; Centro Hospitalario Pereira Rossell (Uruguay). Departamento de Obstetricia y Ginecología Ropero Alba María, Pan American Health Organization (E.E.U.U.) Jacob Serruya Suzanne, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva Pastor Desiré, Pan American Health Organization (E.E.U.U.) Chiu Mónica, Pan American Health Organization (E.E.U.U.) Velandia-Gonzalez Martha, Pan American Health Organization (E.E.U.U.) Abalos Edgardo, Centro de Estudios de Estado y Sociedad (Argentina) Durán Pablo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva Gomez Ponce de León Rodolfo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva Tomasso Giselle, Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay) Mainero Luis, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva Rubino Marcelo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva De Mucio Bremen, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva |
| dc.creator.none.fl_str_mv | Macías Saint-Gerons, Diego Castro, José Luis Colomar, Mercedes Rojas, Edgard Sosa, Claudio Ropero, Alba María Jacob Serruya, Suzanne Pastor, Desiré Chiu, Mónica Velandia-Gonzalez, Martha Abalos, Edgardo Durán, Pablo Gomez Ponce de León, Rodolfo Tomasso, Giselle Mainero, Luis Rubino, Marcelo De Mucio, Bremen |
| dc.date.accessioned.none.fl_str_mv | 2026-07-15T15:48:03Z |
| dc.date.available.none.fl_str_mv | 2026-07-15T15:48:03Z |
| dc.date.issued.none.fl_str_mv | 2024 |
| dc.description.abstract.none.fl_txt_mv | Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals. |
| dc.format.extent.es.fl_str_mv | 10 p. |
| dc.format.mimetype.es.fl_str_mv | application/pdf |
| dc.identifier.citation.es.fl_str_mv | Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p. |
| dc.identifier.doi.none.fl_str_mv | 10.1136/bmjopen-2023-073095 |
| dc.identifier.eissn.none.fl_str_mv | 2044-6055 |
| dc.identifier.uri.none.fl_str_mv | https://hdl.handle.net/20.500.12008/56078 |
| dc.language.iso.none.fl_str_mv | en eng |
| dc.publisher.es.fl_str_mv | BMJ Publishing Group |
| dc.relation.none.fl_str_mv | BMJ Open. 2024;14(1) |
| dc.rights.license.none.fl_str_mv | Licencia Creative Commons Atribución (CC - By 4.0) |
| dc.rights.none.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.source.none.fl_str_mv | reponame:COLIBRI instname:Universidad de la República instacron:Universidad de la República |
| dc.subject.es.fl_str_mv | COVID-19 Maternal medicine Perinatology |
| dc.subject.other.es.fl_str_mv | VACUNAS CONTRA LA COVID-19 PERINATOLOGÍA EFECTOS ADVERSOS A LARGO PLAZO EPIDEMIOLOGÍA PREVENCIÓN DE ENFERMEDADES ESTUDIOS DE CASOS Y CONTROLES MUJERES EMBARAZO ENSAYOS CLÍNICOS COMO ASUNTO RETARDO DEL CRECIMIENTO FETAL INMUNIZACIÓN VACUNACIÓN RECIÉN NACIDO RECIÉN NACIDO PREMATURO ESTUDIOS RETROSPECTIVOS MORTINATO VACUNAS |
| dc.title.none.fl_str_mv | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| dc.type.es.fl_str_mv | Artículo |
| dc.type.none.fl_str_mv | info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv | info:eu-repo/semantics/publishedVersion |
| description | Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | COLIBRI_add7d664270d51a7d59ca7f029a82ee2 |
| identifier_str_mv | Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p. 10.1136/bmjopen-2023-073095 2044-6055 |
| instacron_str | Universidad de la República |
| institution | Universidad de la República |
| instname_str | Universidad de la República |
| language | eng |
| language_invalid_str_mv | en |
| network_acronym_str | COLIBRI |
| network_name_str | COLIBRI |
| oai_identifier_str | oai:colibri.udelar.edu.uy:20.500.12008/56078 |
| publishDate | 2024 |
| reponame_str | COLIBRI |
| repository.mail.fl_str_mv | karina.camps@seciu.edu.uy |
| repository.name.fl_str_mv | COLIBRI - Universidad de la República |
| repository_id_str | 4771 |
| rights_invalid_str_mv | Licencia Creative Commons Atribución (CC - By 4.0) |
| spelling | Macías Saint-Gerons Diego, Universidad de Valencia (España). Instituto de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Salud Mental. Departamento de MedicinaCastro José Luis, Fundación para la Innovación, la Formación, la Investigación y el Desarrollo Comunitario (España)Colomar Mercedes, Universidad de la República (Uruguay). Facultad de Medicina. Departamento de Medicina Preventiva y Social; Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)Rojas Edgard, Pan American Health Organization (E.E.U.U.). Innovation, Access to Medicines and Health TechnologiesSosa Claudio, Universidad de la República (Uruguay). Facultad de Medicina; Centro Hospitalario Pereira Rossell (Uruguay). Departamento de Obstetricia y GinecologíaRopero Alba María, Pan American Health Organization (E.E.U.U.)Jacob Serruya Suzanne, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaPastor Desiré, Pan American Health Organization (E.E.U.U.)Chiu Mónica, Pan American Health Organization (E.E.U.U.)Velandia-Gonzalez Martha, Pan American Health Organization (E.E.U.U.)Abalos Edgardo, Centro de Estudios de Estado y Sociedad (Argentina)Durán Pablo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaGomez Ponce de León Rodolfo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaTomasso Giselle, Unidad de Investigación Clínica y Epidemiológica Montevideo (Uruguay)Mainero Luis, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaRubino Marcelo, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y ReproductivaDe Mucio Bremen, Organización Panamericana de la Salud (Uruguay). Centro Latinoamericano de Perinatología. Salud de la Mujer y Reproductiva2026-07-15T15:48:03Z2026-07-15T15:48:03Z2024Macías Saint-Gerons D, Castro J, Colomar M y otros. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol. BMJ Open [en línea]. 2024;14(1). 10 p.https://hdl.handle.net/20.500.12008/5607810.1136/bmjopen-2023-0730952044-6055Introduction: COVID-19 is associated with higher morbimortality in pregnant people compared with non-pregnant people. At present, the benefits of maternal immunisation are considered to outweigh the risks, and therefore, vaccination is recommended during pregnancy. However, additional information is needed on the safety of the vaccines in this population. Methods and analysis: This a retrospective cohort nested case-control study in pregnant people who attended maternity hospitals from eight Latin American and Caribbean countries. A perinatal electronic clinical history database with neonatal and obstetric information will be used. The proportion of pregnant people immunised with COVID-19 vaccines of the following maternal and neonatal events will be described: preterm infant, small for gestational age, low birth weight, stillbirth, neonatal death, congenital malformations, maternal near miss and maternal death. Moreover, the risk of prematurity, small for gestational age and low birth weight associated with exposure to COVID-19 vaccines will be estimated. Each case will be matched with two groups of three randomly selected controls. Controls will be matched by hospital and mother's age (±3 years) with an additional matching by delivery date and conception time in the first and second control groups, respectively. The estimated required sample size for the main analysis (exposure to any vaccine) concerning 'non-use' is at least 1009 cases (3027 controls) to detect an increased probability of vaccine-associated event risk of 30% and at least 650 cases (1950 controls) to detect 30% protection. Sensitivity and secondary analyses considering country, type of vaccine, exposure windows and completeness of immunisation will be reported. Ethics: The study protocol was reviewed by the Ethical Review Committee on Research of the Pan American Health Organization. Patient informed consent was waived due to the retrospective design and the utilisation of anonymised data (Ref. No: PAHOERC.0546.01). Results will be disseminated in open access journals.Submitted by Almiñana María Cecilia (marialminana@gmail.com) on 2026-07-14T15:59:36Z No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5)Approved for entry into archive by Almiñana María Cecilia (marialminana@gmail.com) on 2026-07-14T16:41:41Z (GMT) No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5)Made available in DSpace by Luna Fabiana (fabiana.luna@seciu.edu.uy) on 2026-07-15T15:48:03Z (GMT). No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Description of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdf: 4619396 bytes, checksum: c2a37d8e741656a7970bf5ee53588199 (MD5) Previous issue date: 202410 p.application/pdfenengBMJ Publishing GroupBMJ Open. 2024;14(1)Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC - By 4.0)COVID-19Maternal medicinePerinatologyVACUNAS CONTRA LA COVID-19PERINATOLOGÍAEFECTOS ADVERSOS A LARGO PLAZOEPIDEMIOLOGÍAPREVENCIÓN DE ENFERMEDADESESTUDIOS DE CASOS Y CONTROLESMUJERESEMBARAZOENSAYOS CLÍNICOS COMO ASUNTORETARDO DEL CRECIMIENTO FETALINMUNIZACIÓNVACUNACIÓNRECIÉN NACIDORECIÉN NACIDO PREMATUROESTUDIOS RETROSPECTIVOSMORTINATOVACUNASDescription of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocolArtículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaMacías Saint-Gerons, DiegoCastro, José LuisColomar, MercedesRojas, EdgardSosa, ClaudioRopero, Alba MaríaJacob Serruya, SuzannePastor, DesiréChiu, MónicaVelandia-Gonzalez, MarthaAbalos, EdgardoDurán, PabloGomez Ponce de León, RodolfoTomasso, GiselleMainero, LuisRubino, MarceloDe Mucio, BremenLICENSElicense.txtlicense.txttext/plain; charset=utf-84267http://localhost:8080/xmlui/bitstream/20.500.12008/56078/5/license.txt6429389a7df7277b72b7924fdc7d47a9MD55CC-LICENSElicense_urllicense_urltext/plain; charset=utf-844http://localhost:8080/xmlui/bitstream/20.500.12008/56078/2/license_urla0ebbeafb9d2ec7cbb19d7137ebc392cMD52license_textlicense_texttext/html; charset=utf-831351http://localhost:8080/xmlui/bitstream/20.500.12008/56078/3/license_textc2be1a593bc16fa3ffa80ce838a200caMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-825630http://localhost:8080/xmlui/bitstream/20.500.12008/56078/4/license_rdfe7132498e7c1fe99f7096667baa99b25MD54ORIGINALDescription of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdfDescription of maternal and neonatal adverse events in pregnant people immunised with COVID19 vaccines.pdfapplication/pdf4619396http://localhost:8080/xmlui/bitstream/20.500.12008/56078/1/Description+of+maternal+and+neonatal+adverse+events+in+pregnant+people+immunised+with+COVID19+vaccines.pdfc2a37d8e741656a7970bf5ee53588199MD5120.500.12008/560782026-07-15 12:48:03.021oai:colibri.udelar.edu.uy:20.500.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Institucionalhttps://www.colibri.udelar.edu.uyUniversidadhttps://udelar.edu.uy/https://www.colibri.udelar.edu.uy/oai/requestkarina.camps@seciu.edu.uyUruguayopendoar:47712026-07-15T15:48:03COLIBRI - Universidad de la Repúblicafalse |
| spellingShingle | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol Macías Saint-Gerons, Diego COVID-19 Maternal medicine Perinatology VACUNAS CONTRA LA COVID-19 PERINATOLOGÍA EFECTOS ADVERSOS A LARGO PLAZO EPIDEMIOLOGÍA PREVENCIÓN DE ENFERMEDADES ESTUDIOS DE CASOS Y CONTROLES MUJERES EMBARAZO ENSAYOS CLÍNICOS COMO ASUNTO RETARDO DEL CRECIMIENTO FETAL INMUNIZACIÓN VACUNACIÓN RECIÉN NACIDO RECIÉN NACIDO PREMATURO ESTUDIOS RETROSPECTIVOS MORTINATO VACUNAS |
| status_str | publishedVersion |
| title | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| title_full | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| title_fullStr | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| title_full_unstemmed | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| title_short | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| title_sort | Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites: nested case–control analysis of the immunization-associated risk – a study protocol |
| topic | COVID-19 Maternal medicine Perinatology VACUNAS CONTRA LA COVID-19 PERINATOLOGÍA EFECTOS ADVERSOS A LARGO PLAZO EPIDEMIOLOGÍA PREVENCIÓN DE ENFERMEDADES ESTUDIOS DE CASOS Y CONTROLES MUJERES EMBARAZO ENSAYOS CLÍNICOS COMO ASUNTO RETARDO DEL CRECIMIENTO FETAL INMUNIZACIÓN VACUNACIÓN RECIÉN NACIDO RECIÉN NACIDO PREMATURO ESTUDIOS RETROSPECTIVOS MORTINATO VACUNAS |
| url | https://hdl.handle.net/20.500.12008/56078 |